Cardiac dysrhythmias and thyroid dysfunction: The hidden menace?

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 3, 2002, Pages 963-967

  Osman, Faizel ^a   Gammage, Michael D ^a   Sheppard, Michael C ^a   Franklyn, Jayne A ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LIOTHYRONINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ANTICOAGULANT THERAPY; ARRHYTHMOGENESIS; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVERSION; CEREBROVASCULAR DISEASE; DNA RESPONSIVE ELEMENT; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART RATE VARIABILITY; HEART RHYTHM; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; HYPERTHYROIDISM; INCIDENCE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK BENEFIT ANALYSIS; SINUS TACHYCARDIA; SUPRAVENTRICULAR PREMATURE BEAT; SUPRAVENTRICULAR TACHYCARDIA; THYROTOXICOSIS; PHYSIOLOGY;

ARRHYTHMIA; ATRIAL FIBRILLATION; HUMANS; HYPERTHYROIDISM; THYROID HORMONES;

EID: 85047687890     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.3.8217     Document Type: Review

References (33)

1. Tunbridge W, Evered D, Hall R 1977 The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 7:481-493
2. Klein I, Ojamaa K 2001 Thyroid hormone and the cardiovascular system. N Engl J Med 344:501-509
3. Franklyn J, Maisonneuve P, Sheppard M, Betteridge J, Boyle P 1998 Mortality after treatment of hyperthyroidism with radioactive iodine. N Engl J Med 338:712-718
4. Goldman MB, Maloof F, Monson RR, Aschengrau A, Cooper DS, Ridgway EC 1988 Radioactive iodine therapy and breast cancer. A follow-up study of hyperthyroid women. Am J Epidemiol 127:969-980
5. Hall P, Lundell G, Holm LE 1993 Mortality in patients treated for hyperthyroidism with iodine-131. Acta Endocrinol 128:230-234
6. Peters A, Ehlers M, Blank B, Exler D, Falk C, Kohlmann T, Fruehwald-Schultes B, Wellhoener P, Kerner W, Fehm HL 2000 Excess triiodothyronine as a risk factor of coronary events. Arch Intern Med 160:1993-1999
7. Parle J, Maisonneuve P, Sheppard M, Boyle P, Franklyn J 2001 A single low serum thyrotrophin (TSH) concentration predicts increased all-cause and cardiovascular mortality in older persons in the community: a 10-year cohort study. Lancet 358:861-865
8. Peterson P, Hansen J 1988 Stroke in thyrotoxicosis with atrial fibrillation. Stroke 19:15-18
9. Sawin C, Geller A, Wolf P, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D'Agostino RB 1994 Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249-1252
10. Bar Sela S, Ehrenfeld M, Eliakim M 1981 Arterial embolism in thyrotoxicosis with atrial fibrillation. Arch Intern Med 141:1191-1192
11. Bagchi N, Brown T, Parish R 1990 Thyroid dysfunction in adults over age 55 years. A study in an urban US community. Arch Intern Med 150:785-787
12. Parle J, Franklyn J, Cross K, Jones C 1991 Prevalence and follow-up of abnormal thyrotropin concentrations in the elderly in the United Kingdom. Clin Endocrinol 34:77-83
13. Toft AD2001 Clinical practice. Subclinical hyperthyroidism. [Review] [35 refs]. N Engl J Med 345:512-516
14. Koutras D 1999 Subclinical hyperthyroidism. Thyroid 9:311-315
15. Haissaguerre M, Jais P, Shah D, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J 1998 Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659-666
16. Von Olshausen K, Bischoff S, Kahaly G, Mohr-Kahaly S, Erbel R, Beyer J, Meyer J 1989 Cardiac arrhythmias and heart rate in hyperthyroidism. Am J Cardiol 63:930-933
17. Osman F, Daykin J, Sheppard M, Franklyn J, Gammage M 2000 Cardiac rhythm abnormalities in thyrotoxicosis - the explanation for excess vascular mortality. J Endocrinol 164:P321
18. Polikar R, Burger AG, Scherrer U, Nicod P 1993 The thyroid and the heart. [Review] [97 refs]. Circulation 87:1435-1441
19. Vanderpump M, Ahlquist J, Franklyn J, Clayton R 1996 Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. BMJ 313:539-544
20. Presti C, Hart R 1989 Thyrotoxicosis, atrial fibrillation, and embolism, revisited. Am Heart J 117:976-977
21. Miller V, Pearce L, Feinberg W, Rothrock J, Anderson D, Hart R 1996 Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation. Neurology 46:238-240
22. Nakazawa H, Sakuri K, Hamada N, Momotani N, Ito K 1982 Management of atrial fibrillation in post-thyrotoxic state. Am J Med 72:903-906
23. Dillmann W 1990 Biochemical basis of thyroid hormone action in the heart. Am J Med 88:626-630
24. Kiss E, Jakab G, Kranias E, Edes I 1994 Thyroid hormone induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum calcium transport and myocardial relaxation. Circ Res 75:245-251
25. Ojamaa K, Sabet A, Kenessey A, Shenoy R, Klein I 1999 Regulation of rat cardiac Kv1.5 gene expression by thyroid hormone is rapid and chamber specific. Endocrinology 140:3170-3176
26. Golf S, Lovstad R, Hansson V 1985 Beta-adrenoceptor density and relative number of beta-adrenoceptor subtypes in biopsies from human right atrial, left ventricular, and right ventricular myocard. Cardiovasc Res 19:636-641
27. Stiles G, Taylor S, Lefkowitz R 1983 Human cardiac beta-adrenergic receptors: subtype heterogeneity delineated by direct radioligand binding. Life Sci 33:467-473
28. Dratman M, Goldman M, Crutchfield F, Gordon J 1982 Nervous system role of iodocompounds in blood pressure regulation. Life Sci 30:611-622
29. Maciel B, Gallo L, Marin Neto J, Maciel L, Martins L 1988 Autonomic control of heart rate during dynamic exercise in human hyperthyroidism. Clin Sci 75:209-215
30. Cacciatori V, Bellavere F, Pezzarossa A, Dellera A, Gemma ML, Thomaseth K, Castello R, Moghetti P, Muggeo M 1996 Power spectral analysis of heart rate in hyperthyroidism. J Clin Endocrinol Metab 81:2828-2835
31. Kollai B, Kollai M 1988 Reduced cardiac vagal excitability in hyperthyroidism. Brain Res Bull 20:785-790
32. Pitzalis MV, Mastropasqua F, Massari F, Ciampolillo A, Passantino A, Ognissanti M, Mannarini A, Zanna D, Giorgino R, Rizzon P 1998 Assessment of cardiac vagal activity in patients with hyperthyroidism. Int J Cardiol 64:145-151
33. Inukai T, Kobayashi I, Kobayashi T, Ishii A, Yamaguchi T, Yamaguchi Y, Iwashita A, Ohshima K, Shimomura Y, Kobayashi S 1990 Parasympathetic nervous system activity in hypothyroidism determined by RR interval variations on electrocardiogram. J Intern Med 228:431-434